title: Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol.
abstract: Liver transplantation is the only definitive treatment for end-stage cirrhosis and fulminant liver failure, but the lack of available donor livers is a major obstacle to liver transplantation. Recently, induced pluripotent stem cells (iPSCs) derived from the reprogramming of somatic fibroblasts, have been shown to resemble embryonic stem (ES) cells in that they have pluripotent properties and the potential to differentiate into all cell lineages in vitro, including hepatocytes. Thus, iPSCs could serve as a favorable cell source for a wide range of applications, including drug toxicity testing, cell transplantation, and patient-specific disease modeling. Here, we describe an efficient and rapid three-step protocol that is able to rapidly generate hepatocyte-like cells from human iPSCs. This occurs because the endodermal induction step allows for more efficient and definitive endoderm cell formation. We show that hepatocyte growth factor (HGF), which synergizes with activin A and Wnt3a, elevates the expression of the endodermal marker Foxa2 (forkhead box a2) by 39.3% compared to when HGF is absent (14.2%) during the endodermal induction step. In addition, iPSC-derived hepatocytes had a similar gene expression profile to mature hepatocytes. Importantly, the hepatocyte-like cells exhibited cytochrome P450 3A4 (CYP3A4) enzyme activity, secreted urea, uptake of low-density lipoprotein (LDL), and possessed the ability to store glycogen. Moreover, the hepatocyte-like cells rescued lethal fulminant hepatic failure in a nonobese diabetic severe combined immunodeficient mouse model.
  
  
  CONCLUSIONS
  We have established a rapid and efficient differentiation protocol that is able to generate functional hepatocyte-like cells from human iPSCs. This may offer an alternative option for treatment of liver diseases.
authors.affiliation: Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan.
authors.forename: Yu-Fan
authors.initials: YF
authors.lastname: Chen
authors.forename: Chien-Yu
authors.initials: CY
authors.lastname: Tseng
authors.forename: Hsei-Wei
authors.initials: HW
authors.lastname: Wang
authors.forename: Hung-Chih
authors.initials: HC
authors.lastname: Kuo
authors.forename: Vincent W
authors.initials: VW
authors.lastname: Yang
authors.forename: Oscar K
authors.initials: OK
authors.lastname: Lee
mesh_terms: D000818:Animals; D002251:Carbon Tetrachloride / Q000009:adverse effects; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology*; D019070:Cell Lineage; D017690:Cell Transplantation / Q000379:methods*; D002478:Cells, Cultured; D004195:Disease Models, Animal; D020869:Gene Expression Profiling; D005973:Glutamine / Q000494:pharmacology; D017228:Hepatocyte Growth Factor / Q000494:pharmacology; D022781:Hepatocytes / Q000166:cytology* / Q000502:physiology / Q000637:transplantation; D006801:Humans; D066298:In Vitro Techniques; D017093:Liver Failure / Q000139:chemically induced / Q000628:therapy; D051379:Mice; D016513:Mice, SCID; D053683:Oncostatin M / Q000494:pharmacology; D039904:Pluripotent Stem Cells / Q000166:cytology* / Q000502:physiology; D016896:Treatment Outcome
chemical_list: D005973:Glutamine; D053683:Oncostatin M; D017228:Hepatocyte Growth Factor; D002251:Carbon Tetrachloride
references.citation: Cell Stem Cell. 2009 Jul 2;5(1):111-23
references.pmid: 19570518
references.citation: Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12301-6
references.pmid: 18719101
references.citation: Hepatology. 2010 Jan;51(1):297-305
references.pmid: 19998274
references.citation: Stem Cell Rev Rep. 2010 Dec;6(4):622-32
references.pmid: 20821352
references.citation: Cloning Stem Cells. 2007 Spring;9(1):51-62
references.pmid: 17386014
references.citation: Trends Mol Med. 2010 Jan;16(1):37-45
references.pmid: 20031486
references.citation: Nat Biotechnol. 2005 Dec;23(12):1534-41
references.pmid: 16258519
references.citation: Genes Dev. 2003 Jul 1;17(13):1646-62
references.pmid: 12842913
references.citation: Mech Dev. 2003 Nov;120(11):1351-83
references.pmid: 14623443
references.citation: Cell. 2007 Nov 30;131(5):861-72
references.pmid: 18035408
references.citation: Hepatology. 2007 May;45(5):1229-39
references.pmid: 17464996
references.citation: Stem Cells. 2008 Apr;26(4):894-902
references.pmid: 18238852
references.citation: Gastroenterology. 2008 Jun;134(7):2111-21, 2121.e1-3
references.pmid: 18455168
references.citation: Nature. 1995 Feb 23;373(6516):699-702
references.pmid: 7854452
references.citation: Nat Biotechnol. 2001 Oct;19(10):971-4
references.pmid: 11581665
references.citation: Hepatology. 2004 Dec;40(6):1275-84
references.pmid: 15562440
references.citation: Stem Cells Dev. 2005 Dec;14(6):643-55
references.pmid: 16433619
references.citation: Hepatology. 2010 May;51(5):1754-65
references.pmid: 20301097
references.citation: Differentiation. 2004 Jun;72(5):230-8
references.pmid: 15270779
references.citation: Nat Protoc. 2008;3(7):1180-6
references.pmid: 18600223
references.citation: Cell Res. 2009 Nov;19(11):1233-42
references.pmid: 19736565
references.citation: J Biol Chem. 2010 Oct 22;285(43):33510-33519
references.pmid: 20720011
references.citation: Nat Cell Biol. 2000 Feb;2(2):76-83
references.pmid: 10655586
references.citation: Hepatology. 2010 Jan;51(1):329-35
references.pmid: 19877180
references.citation: J Clin Invest. 2010 Sep;120(9):3127-36
references.pmid: 20739751
references.citation: N Engl J Med. 1993 Dec 16;329(25):1862-72
references.pmid: 8305063
references.citation: Gastroenterology. 2003 Jun;124(7):1891-900
references.pmid: 12806622
references.citation: Cell Transplant. 2003;12(1):1-11
references.pmid: 12693659
references.citation: Nat Protoc. 2008;3(9):1435-43
references.pmid: 18772870
references.citation: EMBO J. 2006 Aug 9;25(15):3534-45
references.pmid: 16858414